Intelligent Bio Solutions INBS
NASDAQ INBS
$1.67 +0.15 (+9.87%)
At close: Oct 20, 2026 · 4:00 PM EDT

Intelligent Bio Solutions (INBS) Short term Debt (2020)

Updated

Intelligent Bio Solutions (INBS) recorded Short term Debt of $5.13 million in fiscal Q4 2020 (quarter ended Jun 30, 2020).

Analysis

Intelligent Bio Solutions (INBS) Short term Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 254.87 Bn 233.89 Bn 4.88 Bn
2 Abbott Laboratories 178.85 Bn 149.28 Bn 7.27 Bn
3 Danaher 158.49 Bn 142.30 Bn 3.61 Bn
4 Intuitive Surgical 154.99 Bn 134.41 Bn 1.96 Bn
5 Medtronic 121.02 Bn 86.28 Bn 6.34 Bn
6 Stryker 116.94 Bn 103.05 Bn 4.50 Bn
7 Boston Scientific 66.98 Bn 61.75 Bn 3.85 Bn
8 Becton Dickinson 53.23 Bn 50.38 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Intelligent Bio Solutions 2.43 Mn -10.82 Mn 536,583.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 5.13 Mn
API Access

Intelligent Bio Solutions Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=INBS&period=max&api_key=YOUR_API_KEY